The Patent Finder

Evotec AG

7 patents currently held · Updated Nov 20, 2026
17 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

4
Ending by 2030
Mar 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

No maintenance fee falls due on this company's record before Nov 20, 2027.

Recent changes

  • 1 term has ended since Aug 22, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 7 of 7

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,859,545Tetrahydronaphthyridine and Tetrahydropyrido[4,3-d]pyrimidine Compounds and Compositions Thereof Useful for the Treatment of Inflammatory and Respiratory Diseases
In force
 · Medium confidence
In forceMedium confidence
US 7,745,451TETRAHYDRONAPHTHYRIDINE AND TETRAHYDROPYRIDO[4,3-d]PYRIMIDINE COMPOUNDS AND COMPOSITIONS THEREOF USEFUL IN THE TREATMENT OF CONDITIONS ASSOCIATED WITH NEUROLOGICAL AND INFLAMMATORY DISORDERS AND DYSFUNCTIONS
In force
 · High confidence
In forceHigh confidence
US 8,574,861PPM1E proteins and nucleic acids as targets for neurodegenerative diseases
In force
 · USPTO record
In forceUSPTO record
US 8,912,176Azetidines as Histamine H3 Receptor Antagonists
In force
 · High confidence
In forceHigh confidence
US 10,174,0161,3-Thiazol-2-YL Substituted Benzamides
In force
 · Medium confidence
In forceMedium confidence
US 10,183,9371,3-Thiazol-2-YL Substituted Benzamides
In force
 · Medium confidence
In forceMedium confidence
US 10,202,3691,3-Thiazol-2-YL Substituted Benzamides
In force
 · Medium confidence
In forceMedium confidence
Also on record, not counted in the 7: 17 patents in force now held by others · 26 lapsed for an unpaid fee · 18 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

3 abandoned · 7 no status recorded

Showing 1 to 10 of 10, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
17/463,065Methods for Reduction of Pathological Fibrosis and Associated Disorders and DiseasesAug 31, 2021Abandoned
15/756,814Methods for Reduction of Pathological Fibrosis and Associated Disorders and DiseasesSep 2, 2016Abandoned
14/073,981Nov 7, 2013No status recorded
13/452,443Apr 20, 2012No status recorded
12/935,293Mar 27, 2009No status recorded
12/594,789Apr 7, 2008No status recorded
11/838,178Aug 13, 2007No status recorded
11/565,054Nov 30, 2006No status recorded
11/341,859Jan 30, 2006Abandoned
11/667,114Nov 8, 2005No status recorded
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited